Ideas
Korean market engine remains semiconductors.
He says the Korean stock market's engine is semiconductors. Semiconductor industry conditions are strong and investor liquidity remains supportive, so semiconductors are the area investors should keep watching and buying.
Buy more Korean semiconductors now.
Vincent remains strongly bullish on Korean semiconductors and says investors should buy more. He acknowledges credit concerns, high P/E ratios, earnings-season worries, and Trump tariff headlines, but argues these are already known bad news, and the market has learned that tariff shocks do not necessarily depress prices, so he keeps a buy-more stance.
Treasury-share cancellation lifts Korean valuations.
The third Commercial Act amendment is expected to require cancellation of newly acquired and existing treasury shares within set periods and to ban using treasury shares for exchangeable bonds. This should lift shareholder returns, ROE, EPS/BPS growth, and valuation multiples, and many companies have already increased buybacks and cancellations.
Buy high-treasury Korean securities firms.
Shinyoung Securities has a treasury-share ratio above 50%, while Mirae Asset Securities and Daishin Securities are above 20%. In the KOSPI 5,000 era, securities earnings are strong, and mandatory treasury-share cancellation should further highlight their value.
DB Insurance offers high dividend, buyback yield.
DB Insurance has a dividend yield around 6-7% and a high treasury-share ratio, making it attractive to asset owners as a dividend stock, especially ahead of March-April shareholder meetings and treasury-cancellation expectations.
Kumho Petrochemical benefits from turnaround, buybacks.
Kumho Petrochemical has a high treasury-share ratio and is part of the petrochemical sector's restructuring and turnaround, making it a cyclical beneficiary of mandatory treasury-share cancellation.
Dividend tax cut favors Korean large-cap value.
The new dividend income separate taxation will cut taxes on cash dividends for high-income investors and could move hundreds of trillions of won from deposits, bonds, and real estate into dividend-paying stocks. This should improve demand for large-cap value, quality, high-dividend Korean stocks.
Wait on Alteogen after royalty miss.
Alteogen's royalty came in below expectations, causing a sharp negative reaction. However, other royalties could reach 4-5%, and because market liquidity is rotating, investors who did not sell into the bad news can wait for a potential recovery rather than panic.
Korean biotech watches for event-driven rebound.
KOSDAQ's recovery needs biotech, which is roughly half of the index. Although rate-cut expectations have been pushed back and Alteogen's royalty miss hurt sentiment, biotech is event-driven and large licensing deals can turn the sector; policy support and risk-capital flows could reach biotech first.
Buy KOSDAQ 150 ETF for rebound.
He prefers the KOSDAQ 150 ETF over individual biotech stocks because KOSDAQ is roughly half biotech, the government is promoting KOSDAQ, and securities firms' risk capital flows could support the index; if KOSPI rises to 6,000-7,000, KOSDAQ should eventually rise too, and the ETF captures that without single-stock volatility.
Stay long Korean equities, watch semiconductors.
He says investors should not get off the bus yet. Ultra-high-net-worth investors are still invested and not selling, the domestic market has non-taxation and policy support, and the market's engine is semiconductors; the trip only ends when semiconductor fundamentals break.
This 3PRO TV (삼프로TV) video, published January 22, 2026,
features Yoo Yong-seok, Vincent
discussing Korean semiconductor sector, Korean high treasury share ratio stocks, 001720.KS, 006800.KS, 003540.KS, 005830.KS, 011780.KS, Korean large-cap value/quality dividend stocks, 196170.KQ, Korean Biotech/Pharma Sector, KOSDAQ 150 ETF, EWY.
11 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Yoo Yong-seok,
Vincent
· Tickers:
Korean semiconductor sector,
Korean high treasury share ratio stocks,
001720.KS,
006800.KS,
003540.KS,
005830.KS,
011780.KS,
Korean large-cap value/quality dividend stocks,
196170.KQ,
Korean Biotech/Pharma Sector,
KOSDAQ 150 ETF,
EWY